Raymond James Financial
ZURA icon

Raymond James Financial’s Zura Bio ZURA Stock Holding History

Raymond James Financial’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$160K Buy
26,892
+383
+1% +$2.31K ﹤0.01% 4933
2025
Q4 		$139K Sell
26,509
-50,100
-65% -$198K ﹤0.01% 4866
2025
Q3 		$332K Sell
76,609
-37,582
-33% -$67.6K ﹤0.01% 4351
2025
Q2 		$120K Sell
114,191
-30,494
-21% -$36.5K ﹤0.01% 4780
2025
Q1 		$187K Sell
144,685
-3,815
-3% -$6.02K ﹤0.01% 4440
2024
Q4 		$371K Buy
+148,500
New +$529K ﹤0.01% 4070

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Raymond James Financial's ZURA Position: Q1 2026 in Review

Raymond James Financial increased its Zura Bio (ZURA) stake by 1.4% in Q1 2026, buying an estimated $2.31K and bringing the position to 26,892 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #4933.

Raymond James Financial first reported a position in ZURA in Q4 2024 and has held it in 6 quarters since. The position peaked at $371K in Q4 2024. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • Raymond James Financial held 26,892 shares of Zura Bio worth $160K as of Q1 2026.
  • Raymond James Financial bought 383 Zura Bio shares in Q1 2026, an estimated $2.31K.
  • Zura Bio made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #4933 holding.
  • Raymond James Financial first reported a position in Zura Bio in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Zura Bio position peaked at $371K in Q4 2024.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.